LONDONRoche Holding AG said Sunday it would pay  billion for a California biotech firm that has yet to turn a profit on a new drug to treat a deadly lung diseasethe latest gamble by a pharmaceutical giant to buy its way into a lucrative corner of the industry The takeover would allow the Swiss company to expand its presence in the treatment of respiratory disorders one of the worlds biggest drug markets Roches offer of  a share represents a  premium over InterMunes closing share price on Friday of 
  